Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease
Gil-Candel, Mayte, Gascón-Cánovas, Juan José, Urbieta-Sanz, Elena, Rentero-Redondo, Lorena, Onteniente-Candela, MarÃa, Iniesta-Navalón, CarlesLanguage:
english
Journal:
International Journal of Clinical Pharmacy
DOI:
10.1007/s11096-020-00978-6
Date:
January, 2020
File:
PDF, 683 KB
english, 2020